Bethanechol

Source: Wikipedia, the free encyclopedia.

Bethanechol
subcutaneous
ATC code
Legal status
Legal status
Identifiers
  • 2-(Carbamoyloxy)-N,N,N-trimethylpropan-1-aminium
JSmol)
  • O=C(OC(C)C[N+](C)(C)C)N
  • InChI=1S/C7H16N2O2/c1-6(11-7(8)10)5-9(2,3)4/h6H,5H2,1-4H3,(H-,8,10)/p+1 checkY
  • Key:NZUPCNDJBJXXRF-UHFFFAOYSA-O checkY
  (verify)

Bethanechol is a

parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors without any effect on nicotinic receptors. Unlike acetylcholine, bethanechol is not hydrolyzed by cholinesterase and will therefore have a long duration of action. Bethanechol is sold under the brand names Duvoid (Roberts), Myotonachol (Glenwood), Urecholine (Merck Frosst), and Urocarb (Hamilton). The name bethanechol refers to its structure as the urethane
of beta-methylcholine.

Medical uses

Bethanechol alleviates dry mouth

bladder and gastrointestinal tract stimulate contraction of the bladder and expulsion of urine
, and increased gastrointestinal motility, respectively. Bethanechol should be used to treat these disorders only after mechanical obstruction is ruled out as a possible cause.

Its potential benefit in the treatment of cerebral palsy has been investigated.[4]

Atropine is given preoperatively to prevent voiding of the bowel/bladder during surgery; then, bethanechol is given postoperatively to revert this action.[5]

Contraindications

Use of bethanechol, as well as all other muscarinic receptor agonists, is contraindicated in patients with

intestinal obstruction and hyperthyroidism
. The parasympathomimetic action of this drug will exacerbate the symptoms of these disorders.

References

  1. ^ "Active substance: bethanechol" (PDF). List of nationally authorised medicinal products, Human Medicines Evaluation Division. European Medicines Agency. 11 February 2021.
  2. PMID 14970777
    .
  3. .
  4. .
  5. ^ Obied H (2011). Cholinergic Pharmacology. CSU.

External links

  • "Bethanechol". Drug Information Portal. U.S. National Library of Medicine.